137310.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

Stats
Today's Volume	56 660.00
Average Volume	244 279
Market Cap	1 224.69B
EPS	KRW-552.00 ( 2023-11-13 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW14.89 (0.15%)

Volume Correlation

Long: 0.14 (neutral)

Short: -0.59 (weak negative)

Signal:(42.795) Neutral

SD BioSensor, Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SD BioSensor, Inc Correlation - Currency/Commodity

0.17
( neutral )

0.07
( neutral )

0.28
( neutral )

0.35
( neutral )

0.20
( neutral )

0.13
( neutral )

SD BioSensor, Inc Financials

Annual	2023
Revenue:	KRW655.68B
Gross Profit:	KRW29.21B (4.45 %)
EPS:	KRW-4 218.95

Q4	2023
Revenue:	KRW159.61B
Gross Profit:	KRW41.57B (26.04 %)
EPS:	KRW-804.48

Q3	2023
Revenue:	KRW151.03B
Gross Profit:	KRW38.76B (25.67 %)
EPS:	KRW-551.57

Q2	2023
Revenue:	KRW162.64B
Gross Profit:	KRW35.70B (21.95 %)
EPS:	KRW-806.25

Financial Reports:

No articles found.

SD BioSensor, Inc

SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.